Anatoliy Konoplyannikov

Combined therapy with adalimumab and mesenchymal stromal cells contributes to reduction in the degree of inflammation in ulcerative colitis

BACKGROUND: One of the new promising methods of treatment of patients with ulcerative colitis (UC) is biological therapy using bone marrow mesenchymal stromal cells (MCS).

Marina Chernova ;

Oleg Knyazev ;

Sergey Khomeriki ;

Dmitriy Kulakov ;

Anna Kagramanova ;

Anatoliy Konoplyannikov ;

Albina Lishchinskaya ;

Asfold Parfenov ;

Mariya Zvyaglova ;

11/20/2018

Mesenchymal Stromal Cells of Bone Marrow Reduce the Risk of Postoperative Recurrence of Crohn`s Disease

BACKGROUND: Crohn's disease (CD) in the form of terminal ileitis occurs in approximately 1/3 of CD patients and is often complicated by the formation of ileum stricture or ileocecal ...

Anait Babayan ;